What is XOMA Corporation's AOCI?

XOMA Corporation (XOMA) reported AOCI of $119K in Q1 2026.

How has XOMA Corporation's AOCI changed year-over-year?

XOMA Corporation's AOCI increased by 0.8% year-over-year, from $118K to $119K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

XOMA Corporation XOMA AOCI

AOCI at other companies

Ligand PharmaceuticalsLGND

$5.39M+445%

Theravance BiopharmaTBPH

-$62K—

ZymeworksZYME

-$6.57M-2.5%

Ultragenyx PharmaceuticalRARE

$0+100%

ALN

Alnylam PharmaceuticalsALNY

-$24.89M+33.6%

XencorXNCR

$27K-92.4%

Other financials

Income statement

See full

Revenue$12.3M-22.6%

Operating income-$480.0K-108%

Net income$4.5M+88.6%

EPS (diluted)$0.17+183%

Balance sheet

See full

Cash & equivalents$85.6M-5.2%

Total debt$124.7M+9.0%

Total equity$92.9M+9.7%

Total assets$271.9M+27.8%

Cash flow

See full

Operating cash flow$6.1M+178%

CapEx$3.0K-29.4%

Free cash flow-$2.9M+36.0%

Valuation

See full

Market cap$746.04M+159%

Enterprise value$785.17M+152%

P/E22.1×—

P/S15.4×+8.7×

Profitability

See full

Operating margin10.2%+5.5pp

Net margin69.6%+64.0pp

FCF margin-320%-118pp

Returns & leverage

See full

Return on equity38.1%+35.2pp

Debt / equity1.3×0.0×

Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is XOMA Corporation's AOCI?: XOMA Corporation (XOMA) reported AOCI of $119K in Q1 2026.
How has XOMA Corporation's AOCI changed year-over-year?: XOMA Corporation's AOCI increased by 0.8% year-over-year, from $118K to $119K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.